Wikidata

(Q39178894)

English

PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer

scientific article published on 21 May 2013

In more languages

Statements

title
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
23507703
retrieved
9 September 2017
author name string
Paola Muzi
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
23507703
retrieved
9 September 2017
Margherita Piccolella
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
23507703
retrieved
9 September 2017
Marcella Motta
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
23507703
retrieved
9 September 2017
Ernesto Di Cesare
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
23507703
retrieved
9 September 2017
Vincenzo Tombolini
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
23507703
retrieved
9 September 2017
Claudio Festuccia
series ordinal
12
1 reference
stated in
Europe PubMed Central
PubMed ID
23507703
retrieved
9 September 2017
publication date
21 May 2013
1 reference
stated in
Europe PubMed Central
PubMed ID
23507703
retrieved
9 September 2017
page(s)
321-337
1 reference
stated in
Europe PubMed Central
PubMed ID
23507703
retrieved
9 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39178894&oldid=1856220909"